Prognostic and predictive gene expression signatures in breast cancer

Steven Buechler, Sunil Badve

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Breast cancer patients have varying prognoses and responses to treatment due to the heterogeneity of the disease. This chapter surveys the histopathological features, molecular markers, and multigene signatures used for prognosis and prediction of treatment response. The commercially available gene expression based assays for prognostication/prediction in ER+ breast cancer are briefly described and critically discussed. We analyze the underlying reasons for the comparable significance of these tests at the population level, while the tests are discordant for many individual patients. The current challenges to development of future assays are discussed.

Original languageEnglish (US)
Title of host publicationMolecular Pathology of Breast Cancer
PublisherSpringer International Publishing
Pages269-281
Number of pages13
ISBN (Electronic)9783319417615
ISBN (Print)9783319417592
DOIs
StatePublished - Jan 1 2016

Fingerprint

Transcriptome
Breast Neoplasms
Gene Expression
Therapeutics
Population
Surveys and Questionnaires

Keywords

  • Intrinsic classification
  • Mammaprint oncotype DX and prosigna
  • Nottingham prognostic index

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Buechler, S., & Badve, S. (2016). Prognostic and predictive gene expression signatures in breast cancer. In Molecular Pathology of Breast Cancer (pp. 269-281). Springer International Publishing. https://doi.org/10.1007/978-3-319-41761-5_18

Prognostic and predictive gene expression signatures in breast cancer. / Buechler, Steven; Badve, Sunil.

Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. p. 269-281.

Research output: Chapter in Book/Report/Conference proceedingChapter

Buechler, S & Badve, S 2016, Prognostic and predictive gene expression signatures in breast cancer. in Molecular Pathology of Breast Cancer. Springer International Publishing, pp. 269-281. https://doi.org/10.1007/978-3-319-41761-5_18
Buechler S, Badve S. Prognostic and predictive gene expression signatures in breast cancer. In Molecular Pathology of Breast Cancer. Springer International Publishing. 2016. p. 269-281 https://doi.org/10.1007/978-3-319-41761-5_18
Buechler, Steven ; Badve, Sunil. / Prognostic and predictive gene expression signatures in breast cancer. Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. pp. 269-281
@inbook{dad1981a77cf4003b3856690d15ee500,
title = "Prognostic and predictive gene expression signatures in breast cancer",
abstract = "Breast cancer patients have varying prognoses and responses to treatment due to the heterogeneity of the disease. This chapter surveys the histopathological features, molecular markers, and multigene signatures used for prognosis and prediction of treatment response. The commercially available gene expression based assays for prognostication/prediction in ER+ breast cancer are briefly described and critically discussed. We analyze the underlying reasons for the comparable significance of these tests at the population level, while the tests are discordant for many individual patients. The current challenges to development of future assays are discussed.",
keywords = "Intrinsic classification, Mammaprint oncotype DX and prosigna, Nottingham prognostic index",
author = "Steven Buechler and Sunil Badve",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-41761-5_18",
language = "English (US)",
isbn = "9783319417592",
pages = "269--281",
booktitle = "Molecular Pathology of Breast Cancer",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Prognostic and predictive gene expression signatures in breast cancer

AU - Buechler, Steven

AU - Badve, Sunil

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Breast cancer patients have varying prognoses and responses to treatment due to the heterogeneity of the disease. This chapter surveys the histopathological features, molecular markers, and multigene signatures used for prognosis and prediction of treatment response. The commercially available gene expression based assays for prognostication/prediction in ER+ breast cancer are briefly described and critically discussed. We analyze the underlying reasons for the comparable significance of these tests at the population level, while the tests are discordant for many individual patients. The current challenges to development of future assays are discussed.

AB - Breast cancer patients have varying prognoses and responses to treatment due to the heterogeneity of the disease. This chapter surveys the histopathological features, molecular markers, and multigene signatures used for prognosis and prediction of treatment response. The commercially available gene expression based assays for prognostication/prediction in ER+ breast cancer are briefly described and critically discussed. We analyze the underlying reasons for the comparable significance of these tests at the population level, while the tests are discordant for many individual patients. The current challenges to development of future assays are discussed.

KW - Intrinsic classification

KW - Mammaprint oncotype DX and prosigna

KW - Nottingham prognostic index

UR - http://www.scopus.com/inward/record.url?scp=85009686740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009686740&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-41761-5_18

DO - 10.1007/978-3-319-41761-5_18

M3 - Chapter

AN - SCOPUS:85009686740

SN - 9783319417592

SP - 269

EP - 281

BT - Molecular Pathology of Breast Cancer

PB - Springer International Publishing

ER -